Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Movement Disorders · 2026
DOI: 10.1002/mds.70198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Arjun Balachandar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, UHN, and Division o…. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease, Subthalamic Nucleus, Beta Rhythm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chair in Neuromodulation, University of Toronto and University Health Network, Toronto, ON, Canada.
Abstract (Originalsprache)
Background
Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery.
Objectives
Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III).
Results
Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power.
Conclusions
STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, UHN, and Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
- Krembil Brain Institute, Toronto, Ontario, Canada.
- Department of Neurosurgery, Toronto Western Hospital, Toronto, Ontario, Canada.
- Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- IRCCS Humanitas Research Hospital, Milan, Italy.
ORCID-Profile: Arjun Balachandar, Alexandra Boogers
Förderung
- Chair in Neuromodulation, University of Toronto and University Health Network, Toronto, ON, Canada
Zitieren
APA
Balachandar, A., Boogers, A., Naghdlou, S., Lozano, A. M., Kalia, S. K., Tinkhauser, G., & Fasano, A. (2026). Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70198
Vancouver
Balachandar A, Boogers A, Naghdlou S, Lozano AM, Kalia SK, Tinkhauser G, et al. Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70198
BibTeX
@article{Balachandar2026,
author = {Balachandar, Arjun and Boogers, Alexandra and Naghdlou, Sara and Lozano, Andres M and Kalia, Suneil K and Tinkhauser, Gerd and Fasano, Alfonso},
title = {Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70198}
}
EUVIMED